
BLCO Stock Analysis
Bausch + Lomb Corp
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
Performance Overview
Trailing adjusted-close returns as of 2026-06-29. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 24, 2026
BLCO Stock Analysis: Why Bausch + Lomb Corp Scored 33% in Stock Value Finder
Bausch + Lomb Corp (BLCO) StockValueFinder Review
Bausch + Lomb Corp is a healthcare company operating in the medical instruments and supplies industry. This article provides an educational review of BLCO using the metrics from StockValueFinder, a tool designed to help investors evaluate stocks based on financial health indicators.
Why the StockValueFinder Score Matters StockValueFinder evaluates companies across various financial metrics to provide a comprehensive score that reflects their overall financial health. For Bausch + Lomb Corp (BLCO), the score is 33%, which falls below the threshold often considered indicative of strong financial performance. This low score, combined with the AVOID rating, suggests caution when considering investment in BLCO.
EPS Strength and Consistency Earnings Per Share (EPS) measures a company's profitability per share. StockValueFinder evaluates whether a stock has consistent positive EPS over time to ensure earnings stability. For Bausch + Lomb Corp, the EPS test was not passed. While specific historical EPS values are not provided, this indicates that BLCO may have inconsistent or negative EPS figures, which can be a red flag for financial health and future profitability.
ROIC and Capital Efficiency Return on Invested Capital (ROIC) measures how efficiently a company uses its capital to generate returns. A higher ROIC is generally preferred as it suggests better use of resources. Bausch + Lomb Corp's ROIC is -3.05%, which is significantly negative, failing the StockValueFinder test for this metric. In contrast, an ideal ROIC would be 10% or higher, indicating that BLCO is not effectively utilizing its capital compared to companies with a positive and robust ROIC.
Interest Coverage and Financial Safety Interest coverage measures a company's ability to meet interest payments on outstanding debt. A ratio of at least 6 is generally considered healthy by StockValueFinder. Bausch + Lomb Corp did not pass the interest coverage test, suggesting potential financial instability due to high levels of debt or insufficient earnings to cover interest expenses.
Debt Payback and Balance Sheet Discipline Debt payback years indicate how long it would take a company to repay its total debt using current net income. A shorter period is preferable as it indicates better balance sheet health. Bausch + Lomb Corp's debt payback year of -76.41 years, while unusual (as negative values typically suggest no debt), passes the test because it implies zero debt obligations. However, this could be misleading if there are off-balance-sheet liabilities or other financial risks not captured in the data.
P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio compares a stock's market value to its earnings per share. A lower P/E is usually preferred as it suggests better valuation discipline, with StockValueFinder typically looking for ratios of 15 or less. Bausch + Lomb Corp’s P/E ratio stands at 34.94, failing the test and indicating that BLCO may be overvalued relative to its earnings.
Moving Average Trend and Entry Timing The moving average trend signal provides insight into short-term price trends. For Bausch + Lomb Corp, the STRONG BUY TREND indicates a favorable near-term outlook based on technical analysis. However, this does not guarantee future gains; it merely suggests that current market conditions favor buying.
Overall Financial Strengths and Weaknesses
Bausch + Lomb Corp’s financial metrics reveal several areas of concern
However, the low debt payback years and strong moving average trend offer some positives but do not outweigh the significant financial risks highlighted by other metrics.
Risks and Limitations Investing in Bausch + Lomb Corp based on current data poses considerable risk due to poor capital efficiency, high valuation relative to earnings, and potential instability from interest coverage. These factors suggest that BLCO might be a speculative investment rather than a stable holding for conservative investors.
Educational Conclusion Understanding financial metrics like EPS consistency, ROIC, interest coverage, debt payback years, P/E ratios, and moving average trends is crucial for evaluating stock performance. For Bausch + Lomb Corp (BLCO), the StockValueFinder score of 33% with an AVOID rating highlights significant risks that may outweigh potential rewards.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.